Reitan Colleen F
SEC insider (Form 3/4/5 filer). CIK 0001740730. Director at MYRIAD GENETICS INC (MYGN) and 1 other issuer. 25 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in SALT LAKE CITY, UT.
Companies Reitan Colleen F has filed insider reports for
- MYRIAD GENETICS INC (MYGN): Director
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Director
Reitan Colleen F
CIK: 0001740730
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Jun 4, 2026MYGN
MYRIAD GENETICS INC
AwardDirect59.7K shares- - May 20, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
AwardDirect671 shares- - Sep 9, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect799 shares at avg. $464.36$371K - Sep 9, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
ExerciseDirect18K shares at avg. $100.65$1.8M - Sep 9, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect1.6K shares at avg. $457.44$752K - Sep 9, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect1.9K shares at avg. $458.86$866K - Sep 9, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect473 shares at avg. $460.71$218K - Sep 9, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect1.4K shares at avg. $459.73$645K - Sep 9, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect2.3K shares at avg. $461.92$1.1M - Sep 9, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect1.7K shares at avg. $463.00$765K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  MYGN MYRIAD GENETICS INC | Award | 59,701 | - | $0 | Direct |
| May 20, 2026 |  ALNY ALNYLAM PHARMACEUTICALS, INC. | Award | 671 | - | $0 | Direct |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 799 | $464.36 | $371,024 | Direct |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Exercise | 18,000 | $100.65 | $1,811,700 | Direct |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 1,645 | $457.44 | $752,489 | Direct |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 1,888 | $458.86 | $866,328 | Direct |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 473 | $460.71 | $217,916 | Direct |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 1,403 | $459.73 | $645,001 | Direct |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 2,290 | $461.92 | $1,057,797 | Direct |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 1,652 | $463.00 | $764,876 | Direct |
1-10 of 25 transactions